Study ID: B7981080 for Vitiligo
Summary
This study is to test the safety and effectiveness of a once daily oral treatment for non segmental vitiligo.
Currently there are no oral medications approved for treating non segmental vitiligo.
The study drug has already been approved for use in treating another autoimmune condition, but its effectiveness in treating vitiligo still requires research.
This is a placebo controlled trial, which means there is a possibility you will receive the placebo (which has no medicine).
There is a greater chance to receive the active drug than the placebo.
Study medicine and any trial-related
procedures are generally covered at no cost.
Volunteers are needed to help verify whether new treatments should be released to the public. Your participation in our clinical trial helps the medical community develop treatments that can help millions of people.
If you have non segmental vitiligo, and want to help us research innovative treatments by trying them with us, read on to the inclusion criteria.
There are other criteria that our clinical staff will discuss with you as well.
Inclusion Criteria
You are eligible* to participate in the study if:
You are 18 or older.
You have been diagnosed with non segmental vitiligo for at least 3 months.
Your vitiligo is either active or stable.
You have vitiligo on both your face and body, covering between 4% and 60% of your body.
* Additional criteria for eligibility apply
If study investigators determine you are eligible, your participation may help find a potential treatment option for you and others with non segmental vitiligo
If you participate in the B7981080 Study, You will be asked to:**
Provide signed informed consent
Comply with all scheduled clinic
visits and study-related
procedures
Not take any study-prohibited
medications during the trial
period
** Additional responsibilities apply
Your participation in the study is entirely voluntary, and your information
will be confidential. If you change your mind, you can withdraw from the study at any
time, for any reason, and without any consequence
What to expect during the study
Beyond the initial screening period, the study lasts up to 26 months
consisting of up to 17 clinic visits to update on your health status, including:***
Routine laboratory
tests
Urinalysis
Physical Exam
Vital signs
Standard assessments for the effectiveness of the drug.
***Additional assessments apply
Contact us about joining the trial
To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.
Fill out this form, or call us to get in touch. Our phone number is # (289)-763-8666.
We will contact you in 1-2 business days regarding your application to participate in the trial.
Privacy Policy for SimcoDerm Clinical Trials
Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.
We collect information directly from you, including your name, contact details, health information, and treatment history.
We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.
Data Protection:
Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.
You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.